# Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

> **NCT00823693** · PHASE2 · COMPLETED · sponsor: **Revotar Biopharmaceuticals AG** · enrollment: 107 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Bimosiamose Cream
- **DRUG:** Placebo Cream

## Key facts

- **NCT ID:** NCT00823693
- **Lead sponsor:** Revotar Biopharmaceuticals AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2009-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823693, "Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00823693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*